• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Interdiscip Cardiovasc Thorac Surg . COVID-19 patients with spontaneous pneumothorax: a propensity-matched, multicentre case-control study

tetano

Editor, Senior Moderator
Interdiscip Cardiovasc Thorac Surg


. 2025 Mar 26:ivaf076.
doi: 10.1093/icvts/ivaf076. Online ahead of print. COVID-19 patients with spontaneous pneumothorax: a propensity-matched, multicentre case-control study

Arianna Farronato[SUP] 1 [/SUP], Chiara Travaglia[SUP] 2 [/SUP], Alice Ravasin[SUP] 1 [/SUP], Vittorio Aprile[SUP] 3 [/SUP], Roberto Corzani[SUP] 4 [/SUP], Elisa Sicolo[SUP] 3 [/SUP], Adriano Peris[SUP] 5 [/SUP], Stefano Romagnoli[SUP] 2 [/SUP], Marco Lucchi[SUP] 3 [/SUP], Piero Paladini[SUP] 4 [/SUP], Luca Voltolini[SUP] 1 [/SUP], Alessandro Gonfiotti[SUP] 1 [/SUP]



Affiliations
Abstract

Objectives: Pneumothorax and pneumomediastinum have been frequently reported in Coronavirus Disease-19 (COVID-19) thus complicating the patient's overall healthcare management and survival rate. The study aimed to evaluate the outcomes of COVID-19 patients, who developed spontaneous pneumothorax or spontaneous pneumomediastinum.
Methods: In this Italian multicentre retrospective cohort study, medical records in non-vaccinated COVID-19 patients, from March 2020 to May 2021, were analyzed. To reduce the risk of bias due to unbalanced groups, a Propensity Score Matching (PSM) approach was applied using logistic regression to estimate propensity scores. Separate multivariable Generalized Linear Models (GLMs) were then used to assess the risk of in-hospital mortality and other outcomes.
Results: 474 patients were assessed, of which 72 patients developed spontaneous pneumothorax or pneumomediastinum. In separate multivariable GLM regression analysis of un-matched cohort spontaneous pneumothorax (OR 2.44, 95% CI 1.7-5.55; p = 0.031) are associated with increase of in-hospital mortality rate, results confirmed even after matching the two cohorts. Spontaneous pneumomediastinum (OR 1.21, 95% CI 1.13-1.30, p < 0.001) and spontaneous pneumothorax (OR 1.34, 95% CI 1.26-1.43, p < 0.001) are associated with increase of length of stay. The risk of in-hospital mortality also increases with age, comorbidities (classified by Charlson comorbidity index), and smoking habits.
Conclusions: Spontaneous pneumothorax in hospitalized COVID-19 patients may be associated with an increased risk of in-hospital mortality and prolonged hospitalization.

Keywords: ARDS; COVID-19; Coronavirus; SARS Cov-2; Spontaneous Pneumomediastinum; Spontaneous Pneumothorax.

 
Back
Top Bottom